Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: peregrine license agreement ?
...During the fiscal years ended May 31, 2017 and 2016, PDS entered into licensing agreements with third parties, pursuant to which PDS recognized revenues of $3,000,000 and $1,450,000, respectively.......
(affiliated company PDS)
 
page 62 - 10k 2017
 

 

Share
New Message
Please login to post a reply